Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.460
+0.150 (11.45%)
At close: May 12, 2025, 4:00 PM
1.450
-0.010 (-0.68%)
After-hours: May 12, 2025, 7:46 PM EDT
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $206.51 million as of May 12, 2025. Its market cap has decreased by -74.73% in one year.
Market Cap
206.51M
Enterprise Value
426.08M
1-Year Change
-74.73%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $206.51M, a decrease of -96.36%. That is a compound annual growth rate of -37.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 192.70M | -33.25% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |